rs139265462

Variant summary

Our verdict is Likely benign. The variant received -5 ACMG points: 2P and 7B. PM1BP4_ModerateBP6BS1

The NM_001256071.3(RNF213):​c.12055C>T​(p.Arg4019Cys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000516 in 1,614,242 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 11/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.00057 ( 0 hom., cov: 33)
Exomes 𝑓: 0.00051 ( 0 hom. )

Consequence

RNF213
NM_001256071.3 missense

Scores

1
5
12

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:3B:1

Conservation

PhyloP100: 0.574

Publications

18 publications found
Variant links:
Genes affected
RNF213 (HGNC:14539): (ring finger protein 213) This gene encodes a protein containing a C3HC4-type RING finger domain, which is a specialized type of Zn-finger that binds two atoms of zinc and is thought to be involved in mediating protein-protein interactions. The protein also contains an AAA domain, which is associated with ATPase activity. This gene is a susceptibility gene for Moyamoya disease, a vascular disorder of intracranial arteries. This gene is also a translocation partner in anaplastic large cell lymphoma and inflammatory myofibroblastic tumor cases, where a t(2;17)(p23;q25) translocation has been identified with the anaplastic lymphoma kinase (ALK) gene on chromosome 2, and a t(8;17)(q24;q25) translocation has been identified with the MYC gene on chromosome 8. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Dec 2011]
RNF213-AS1 (HGNC:54402): (RNF213 antisense RNA 1)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -5 ACMG points.

PM1
In a hotspot region, there are 5 aminoacids with missense pathogenic changes in the window of +-8 aminoacids around while only 0 benign, 3 uncertain in NM_001256071.3
BP4
Computational evidence support a benign effect (MetaRNN=0.12797883).
BP6
Variant 17-80368043-C-T is Benign according to our data. Variant chr17-80368043-C-T is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 210007.We mark this variant Likely_benign, oryginal submission is: [Conflicting_classifications_of_pathogenicity].
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.000571 (87/152362) while in subpopulation NFE AF = 0.00101 (69/68032). AF 95% confidence interval is 0.000821. There are 0 homozygotes in GnomAd4. There are 38 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position passed quality control check.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
RNF213NM_001256071.3 linkc.12055C>T p.Arg4019Cys missense_variant Exon 44 of 68 ENST00000582970.6 NP_001243000.2 Q63HN8A0A0A0MTR7

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
RNF213ENST00000582970.6 linkc.12055C>T p.Arg4019Cys missense_variant Exon 44 of 68 1 NM_001256071.3 ENSP00000464087.1 A0A0A0MTR7

Frequencies

GnomAD3 genomes
AF:
0.000571
AC:
87
AN:
152244
Hom.:
0
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0000965
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0000654
Gnomad ASJ
AF:
0.00317
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.0000941
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00101
Gnomad OTH
AF:
0.000478
GnomAD2 exomes
AF:
0.000565
AC:
142
AN:
251476
AF XY:
0.000537
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.000260
Gnomad ASJ exome
AF:
0.00228
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00102
Gnomad NFE exome
AF:
0.000721
Gnomad OTH exome
AF:
0.000978
GnomAD4 exome
AF:
0.000510
AC:
746
AN:
1461880
Hom.:
0
Cov.:
32
AF XY:
0.000561
AC XY:
408
AN XY:
727244
show subpopulations
African (AFR)
AF:
0.0000597
AC:
2
AN:
33480
American (AMR)
AF:
0.000335
AC:
15
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.00260
AC:
68
AN:
26136
East Asian (EAS)
AF:
0.0000252
AC:
1
AN:
39700
South Asian (SAS)
AF:
0.00
AC:
0
AN:
86258
European-Finnish (FIN)
AF:
0.000917
AC:
49
AN:
53418
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5768
European-Non Finnish (NFE)
AF:
0.000517
AC:
575
AN:
1112000
Other (OTH)
AF:
0.000596
AC:
36
AN:
60396
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.491
Heterozygous variant carriers
0
52
104
155
207
259
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000571
AC:
87
AN:
152362
Hom.:
0
Cov.:
33
AF XY:
0.000510
AC XY:
38
AN XY:
74516
show subpopulations
African (AFR)
AF:
0.0000962
AC:
4
AN:
41584
American (AMR)
AF:
0.0000653
AC:
1
AN:
15312
Ashkenazi Jewish (ASJ)
AF:
0.00317
AC:
11
AN:
3468
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5192
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4826
European-Finnish (FIN)
AF:
0.0000941
AC:
1
AN:
10626
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.00101
AC:
69
AN:
68032
Other (OTH)
AF:
0.000473
AC:
1
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.516
Heterozygous variant carriers
0
4
9
13
18
22
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000739
Hom.:
0
Bravo
AF:
0.000472
TwinsUK
AF:
0.000539
AC:
2
ALSPAC
AF:
0.000259
AC:
1
ESP6500AA
AF:
0.00
AC:
0
ESP6500EA
AF:
0.000930
AC:
8
ExAC
AF:
0.000544
AC:
66
EpiCase
AF:
0.000872
EpiControl
AF:
0.000356

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:3Benign:1
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

Moyamoya disease 2 Uncertain:2
Mar 03, 2017
UMR-S1161, Institut national de la santé et de la recherche médicale
Significance:Uncertain significance
Review Status:no assertion criteria provided
Collection Method:research

- -

Sep 08, 2014
Department of Internal Medicine, University of Texas Health Science Center at Houston
Significance:Uncertain significance
Review Status:no assertion criteria provided
Collection Method:research

- -

not provided Uncertain:1Benign:1
Dec 20, 2023
Mayo Clinic Laboratories, Mayo Clinic
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

BS4, PP2, PS3_supporting, PS4_moderate -

Nov 27, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.11
BayesDel_addAF
Benign
-0.34
T
BayesDel_noAF
Benign
-0.28
CADD
Benign
15
DANN
Uncertain
1.0
DEOGEN2
Benign
0.057
T;T
Eigen
Benign
-0.46
Eigen_PC
Benign
-0.77
FATHMM_MKL
Benign
0.089
N
LIST_S2
Benign
0.70
T;T
M_CAP
Pathogenic
0.39
D
MetaRNN
Benign
0.13
T;T
MetaSVM
Uncertain
-0.057
T
PhyloP100
0.57
PrimateAI
Benign
0.25
T
PROVEAN
Uncertain
-3.4
D;.
REVEL
Uncertain
0.37
Sift
Benign
0.037
D;.
Sift4G
Uncertain
0.053
T;T
Vest4
0.25
MVP
0.60
MPC
0.67
ClinPred
0.14
T
GERP RS
-6.6
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.2
Mutation Taster
=96/4
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs139265462; hg19: chr17-78341843; COSMIC: COSV60408622; COSMIC: COSV60408622; API